loading

Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Expenses
34.45%
2.3072
1.716 1.6171 2.0287 2.2697
Operating Income/Loss
34.45%
-2.3072
-1.716 -1.6171 -2.0287 -2.2697
Net Income/Loss
34.10%
-2.2542
-1.681 -1.5783 -1.9928 -2.2463
Basic Average Shares
56.69%
4.2595
2.7184 - 1.6258 1.1903
Diluted Average Shares
56.69%
4.2595
2.7184 - 1.6258 1.1903
Basic Earnings Per Share
14.52%
-0.53
-0.62 - -1.23 -1.89
Diluted Earnings Per Share
14.52%
-0.53
-0.62 - -1.23 -1.89
$9.76
price down icon 44.16%
$7.49
price up icon 6.39%
ANL ANL
$10.20
price down icon 4.76%
$1.485
price up icon 0.34%
$8.67
price up icon 5.09%
$6.40
price up icon 1.59%
Kapitalisierung:     |  Volumen (24h):